Stifel Financial Corp Ligand Pharmaceuticals Inc Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Stifel Financial Corp holds 15,949 shares of LGND stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,949

Previous 13,661 16.75%

Holding current value

$1.82 Million

Previous $1.15 Million 38.75%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$82.7 - $110.11 $189,217 - $251,931	2,288 Added 16.75%	15,949 $1.6 Million
Q2 2024 Aug 13, 2024	BUY	$68.53 - $87.91 $390,895 - $501,438	5,704 Added 71.69%	13,661 $1.15 Million
Q1 2024 May 13, 2024	BUY	$68.64 - $89.2 $52,921 - $68,773	771 Added 10.73%	7,957 $581,000
Q4 2023 Feb 12, 2024	SELL	$49.57 - $72.63 $9,765 - $14,308	-197 Reduced 2.67%	7,186 $513,000
Q3 2023 Nov 13, 2023	SELL	$58.86 - $72.67 $12,654 - $15,624	-215 Reduced 2.83%	7,383 $442,000
Q2 2023 Aug 14, 2023	BUY	$69.53 - $79.33 $221,661 - $252,904	3,188 Added 72.29%	7,598 $547,000
Q1 2023 May 12, 2023	BUY	$65.67 - $77.08 $289,604 - $339,922	4,410 New	4,410 $324,000
Q1 2021 May 14, 2021	SELL	$99.52 - $215.83 $734,756 - $1.59 Million	-7,383 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$80.55 - $106.05 $44,463 - $58,539	-552 Reduced 6.96%	7,383 $734,000
Q3 2020 Nov 16, 2020	BUY	$89.56 - $126.72 $60,453 - $85,536	675 Added 9.3%	7,935 $755,000
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $197,465 - $357,595	2,892 Added 66.21%	7,260 $812,000
Q1 2020 May 14, 2020	SELL	$63.37 - $107.88 $4.41 Million - $7.51 Million	-69,622 Reduced 94.1%	4,368 $318,000
Q4 2019 Feb 13, 2020	SELL	$96.94 - $113.59 $498,756 - $584,420	-5,145 Reduced 6.5%	73,990 $7.73 Million
Q3 2019 Nov 19, 2019	BUY	$86.25 - $120.16 $25,616 - $35,687	297 Added 0.38%	79,135 $7.81 Million
Q3 2019 Nov 13, 2019	SELL	$86.25 - $120.16 $2.66 Million - $3.71 Million	-30,837 Reduced 28.12%	78,838 $7.78 Million
Q2 2019 Aug 14, 2019	BUY	$107.38 - $129.34 $947,091 - $1.14 Million	8,820 Added 8.75%	109,675 $12.6 Million
Q1 2019 May 14, 2019	SELL	$105.93 - $142.47 $67,901 - $91,323	-641 Reduced 0.63%	100,855 $12.7 Million
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $2.16 Million - $4.59 Million	16,856 Added 19.91%	101,496 $13.8 Million
Q3 2018 Nov 13, 2018	SELL	$211.18 - $274.49 $7.5 Million - $9.74 Million	-35,493 Reduced 29.54%	84,640 $23.2 Million
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $265,355 - $366,044	1,760 Added 1.49%	120,133 $24.9 Million
Q1 2018 May 11, 2018	BUY	$138.63 - $182.62 $829,146 - $1.09 Million	5,981 Added 5.32%	118,373 $19.5 Million
Q4 2017 Feb 14, 2018	BUY	$128.36 - $147.04 $419,480 - $480,526	3,268 Added 2.99%	112,392 $15.4 Million
Q3 2017 Nov 13, 2017	BUY	$120.91 - $137.94 $13.2 Million - $15.1 Million	109,124	109,124 $0

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.93B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Ligand Pharmaceuticals Inc Transaction History